SOLENO THERAPEUTICS INC (SLNO) Stock Balance Sheet
NASDAQ:SLNO • US8342033094
Current stock price
33.62 USD
+0.23 (+0.69%)
At close:
33.85 USD
+0.23 (+0.68%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 70.11M | 87.93M | 169.68M | 14.60M | 21.30M | |||
| Marketable Securities | 235.37M | 203.51M | N/A | N/A | N/A | |||
| Receivables | 28.21M | N/A | N/A | N/A | N/A | |||
| Inventories | 15.02M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 7.11M | 2.45M | 1.68M | 1.05M | 1.12M | |||
| Total Current Assets | 355.81M | 293.89M | 171.36M | 15.65M | 22.42M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.38M | 2.98M | 419.00K | 160.00K | 450.00K | |||
| Investments And Advances | 200.62M | 27.21M | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 4.86M | 6.80M | 8.75M | 10.69M | 12.64M | |||
| Other Non-Current Assets | 163.00K | 83.00K | 165.00K | 0.00 | 40.00K | |||
| Total Non-Current Assets | 208.02M | 37.08M | 9.33M | 10.85M | 13.13M | |||
| TOTAL ASSETS | 563.83M | 330.97M | 180.69M | 26.50M | 35.55M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 14.52M | 7.13M | 6.80M | 5.05M | 4.43M | |||
| Accounts Payable | 12.44M | 8.88M | 3.15M | 1.78M | 3.25M | |||
| Other Current Liabilities | 34.41M | 2.74M | 1.55M | 480.00K | 320.00K | |||
| Total Current Liabilities | 61.36M | 18.75M | 11.51M | 7.31M | 8.01M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 49.86M | 49.83M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.49M | 17.28M | 11.68M | 8.84M | 9.75M | |||
| Total Non-Current Liabilities | 52.35M | 67.11M | 11.68M | 8.84M | 9.75M | |||
| TOTAL LIABILITIES | 113.72M | 85.86M | 23.18M | 16.15M | 17.76M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -431.37M | -452.26M | -276.41M | -237.42M | -213.36M | |||
| Additional Paid In Capital | 881.02M | 696.97M | 433.88M | 247.76M | 231.07M | |||
| Common Shares | 52.00K | 46.00K | 32.00K | 10.00K | 80.00K | |||
| Other Shareholders' Equity | 415.00K | 361.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 52.29M | 45.70M | 31.68M | 8.16M | 5.32M | |||
| Tangible Book Value per Share | 8.52 | 5.21 | 4.70 | -0.04 | 0.97 | |||
| Total Shareholders' Equity | 450.12M | 245.11M | 157.51M | 10.35M | 17.79M | |||
| TOTAL LIABILITIES AND EQUITY | 563.83M | 330.97M | 180.69M | 26.50M | 35.55M | |||
| Statistics | ||||||||
| Debt/Equity | 0.11 | 0.20 | N/A | N/A | N/A | |||
| Current Ratio | 5.80 | 15.68 | 14.89 | 2.14 | 2.80 | |||
| Return On Assets (ROA) | 3.63% | -53.13% | -21.58% | -90.83% | -86.95% | |||
| Return On Equity (ROE) | 4.55% | -71.74% | -24.75% | -232.56% | -173.75% | |||
| Return On Invested Capital (ROIC) | 1.48% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 3.78% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 3.87% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21